Medicine & Pharmaceuticals 

Oncology in Focus: How Emerging Therapies Are Reshaping Cancer Treatment

USA News Group News Commentary – Immunotherapy is transforming oncology by harnessing the immune system's power to fight cancer like never before. Notable advancements include a bioengineered therapeutic platform that...

Oncology in Focus: How Emerging Therapies Are Reshaping Cancer Treatment
Steps to Address Your Hearing Health in 2025

For many people, the start of a new year is the most definitive marker to start fresh. New Year's resolutions provide motivation to individuals looking to take charge of their health and make changes where they see...

Steps to Address Your Hearing Health in 2025
Hoth Therapeutics Enters Partnership with the Department of Veterans Affairs to Develop Obesity Treatment

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company focused on developing innovative therapies, today announced that it has entered into an exclusive patent license agreement with the U.S. Department of...

Hoth Therapeutics Enters Partnership with the Department of Veterans Affairs to Develop Obesity Treatment
Microtech Announces First Human Case of Implantable Microsensor for Heart Failure

Microtech, a wholly owned subsidiary of Medinol Inc., a leader in global MedTech research and development, announced that it has initiated human clinical trials of their microsensor platform, in a trial to measure atrial...

Microtech Announces First Human Case of Implantable Microsensor for Heart Failure
Matwings Technology Raised Series A Funding of Tens of Millions USD to Redefine Protein Design

Recently, Shanghai Matwings Technology Co., Ltd. ('Matwings'), a global leader in AI-driven protein design, announced the successful completion of Series A funding rounds, raising tens of millions of USD, led by...

Matwings Technology Raised Series A Funding of Tens of Millions USD to Redefine Protein Design
Preliminary Results of Qilu Pharmaceutical's Phase Ia Study on GPRC5D/CD3-Targeting Bispecific Antibody QLS32015 Unveiled at 2024 ASH Annual Meeting

During the 66th Annual Meeting of the American Society of Hematology (ASH) held in San Diego from December 7 to 10, preliminary results from the first human trial of QLS32015, a novel anticancer drug developed by Qilu...

Preliminary Results of Qilu Pharmaceutical's Phase Ia Study on GPRC5D/CD3-Targeting Bispecific Antibody QLS32015 Unveiled at 2024 ASH Annual Meeting
Bio-Thera Solutions Partners with Tabuk Pharmaceuticals to Commercialize BAT2206, a Stelara® (Ustekinumab) Biosimilar in Saudi Arabia

Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and a pipeline of biosimilars, today announced the company has partnered with Tabuk...

Bio-Thera Solutions Partners with Tabuk Pharmaceuticals to Commercialize BAT2206, a Stelara® (Ustekinumab) Biosimilar in Saudi Arabia
Mowilex, Indonesia's First Carbon Neutral Manufacturer, Receives CarbonNeutral® Company Certification for the Sixth Consecutive Year

PT Mowilex Indonesia (Mowilex) has achieved its sixth consecutive CarbonNeutral® certification from Climate Impact Partners. Mowilex made history when it became Indonesia's first certified carbon neutral manufacturer...

Mowilex, Indonesia's First Carbon Neutral Manufacturer, Receives CarbonNeutral® Company Certification for the Sixth Consecutive Year
BillionToOne to Present at the 43rd Annual J.P. Morgan Healthcare Conference

BillionToOne, a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that they will be presenting at the 43rd Annual J.P. Morgan...

BillionToOne to Present at the 43rd Annual J.P. Morgan Healthcare Conference
TransMedics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of...

TransMedics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
U.S. District Court Awards 10x Genomics Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today it had secured a permanent injunction in the U.S. District Court for the District of Delaware against the GeoMx products sold...

U.S. District Court Awards 10x Genomics Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products
Heron Therapeutics Announces Corporate Headquarters Relocation to Cary, North Carolina

Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, announced today the relocation of the Company's headquarters from San Diego, California to Cary, North...

Heron Therapeutics Announces Corporate Headquarters Relocation to Cary, North Carolina
Robbins Geller Rudman & Dowd LLP and Scott+Scott Attorneys at Law LLP Announce A Proposed Class Action Settlement If You Purchased or Paid for a Prescription Drug With Insurance At Walgreens from January 1, 2007 through November 18, 2024

If You Purchased or Paid for a Prescription Drug with Insurance At Walgreens,1 A Class Action Settlement Could Affect You. This is not a solicitation from a lawyer. A proposed Settlement2 has been reached in a class...

Robbins Geller Rudman & Dowd LLP and Scott+Scott Attorneys at Law LLP Announce A Proposed Class Action Settlement If You Purchased or Paid for a Prescription Drug With Insurance At Walgreens from January 1, 2007 through November 18, 2024
Safe Life Enters French Market with Strategic Acquisition of D-Sécurité Groupe

Safe Life, a leading provider of life-saving solutions with operations across Europe and North America, announces the acquisition of D-Sécurité Groupe (D-Sécurité), one of the leading French suppliers of AEDs and medical...

Safe Life Enters French Market with Strategic Acquisition of D-Sécurité Groupe
Keymed Biosciences Announces Approval Of Stapokibart For The Treatment Of Chronic Rhinosinusitis With Nasal Polyposis

Keymed Biosciences Inc. (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of Stapokibart (anti-IL-4Ra...

Keymed Biosciences Announces Approval Of Stapokibart For The Treatment Of Chronic Rhinosinusitis With Nasal Polyposis
Sumitomo Pharma America Announces U.S. FDA Approval of GEMTESA® (vibegron) for Men with Overactive Bladder Symptoms Receiving Pharmacological Therapy for Benign Prostatic Hyperplasia

Sumitomo Pharma America, Inc. (SMPA) announced today that the U.S. Food and Drug Administration (FDA) has approved GEMTESA® (vibegron), a beta-3 (ß3) adrenergic receptor agonist, dosed once-daily (75 mg), for the treatment...

Sumitomo Pharma America Announces U.S. FDA Approval of GEMTESA® (vibegron) for Men with Overactive Bladder Symptoms Receiving Pharmacological Therapy for Benign Prostatic Hyperplasia
Fresenius Medical Care Listed in The Dow Jones Sustainability World Index and for the 15th Time in The Dow Jones Sustainability Europe Index

Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, has been recognized as a sustainability leader with the inclusion in the Dow Jones Sustainability...

Fresenius Medical Care Listed in The Dow Jones Sustainability World Index and for the 15th Time in The Dow Jones Sustainability Europe Index
Baird-Sponsored Microwave Ablation Training Enhances Thyroid Treatment

Baird Medical (NASDAQ: BDMD), a leader in minimally invasive Microwave Ablation (MWA) technology, recently sponsored another advanced MWA training session in New Orleans. The program provided hands-on experience with a...

Baird-Sponsored Microwave Ablation Training Enhances Thyroid Treatment
PANTHERx® Rare Selected by Ionis as Specialty Pharmacy for TRYNGOLZA™ (olezarsen)

PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce that it was selected by Ionis Pharmaceuticals, Inc. for the distribution of TRYNGOLZA™...

PANTHERx® Rare Selected by Ionis as Specialty Pharmacy for TRYNGOLZA™ (olezarsen)
Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that it had received written...

Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
NEW CLINICAL PRACTICE GUIDELINE ON THE PROCESS FOR DIAGNOSING ALZHEIMER'S DISEASE OR A RELATED FORM OF COGNITIVE IMPAIRMENT OR DEMENTIA

We have entered a new era of improved and emerging biologically-based diagnostic biomarkers for Alzheimer's disease (AD) and AD-related neurodegenerative disorders (ADRD) that are rapidly impacting evaluation and care...

NEW CLINICAL PRACTICE GUIDELINE ON THE PROCESS FOR DIAGNOSING ALZHEIMER'S DISEASE OR A RELATED FORM OF COGNITIVE IMPAIRMENT OR DEMENTIA
Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu

Traws Pharma, Inc. (NASDAQ: TRAW) ("Traws Pharma", "Traws" or "the Company"), a clinical-stage biopharmaceutical company developing oral small molecule therapies for the treatment of respiratory viral diseases, today...

Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu
TECHTRONIC INDUSTRIES JOINS THE UN GLOBAL COMPACT

Global cordless power tool, outdoor power equipment and floorcare company Techtronic Industries Co. Ltd. ("TTI" or the "Company") (stock code: HK:0669, ADR symbol: TTNDY) today announced that it has joined the United...

TECHTRONIC INDUSTRIES JOINS THE UN GLOBAL COMPACT
CStone Announces Submission of Clinical Trial Application in Australia for CS2009, an Innovative PD-1/VEGF/CTLA-4 Trispecific Antibody

CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therapies, announced today the submission of clinical trial application...

CStone Announces Submission of Clinical Trial Application in Australia for CS2009, an Innovative PD-1/VEGF/CTLA-4 Trispecific Antibody
Stuart Therapeutics Announces the Appointment of Two New Board Members

Stuart Therapeutics announced today the appointment of Tracy Valorie and Jason Werner to the company's Board of Directors, bringing the total number of Board members to five. These new Directors will hold the positions...

Stuart Therapeutics Announces the Appointment of Two New Board Members
YolTech Therapeutics Announces Successful Completion of Dose Escalation Phase in Phase I Trial of YOLT-201 for ATTR

YolTech Therapeutics today announced updated data from its ongoing Phase I/IIa clinical trial of YOLT-201, a first-in-class CRISPR/Cas9-based in vivo gene-editing therapy for ATTR amyloidosis. The trial has completed...

YolTech Therapeutics Announces Successful Completion of Dose Escalation Phase in Phase I Trial of YOLT-201 for ATTR
Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards

Corvia Medical, Inc., a company dedicated to transforming the treatment of heart failure, announced today that it has achieved CE certification for the Corvia® Atrial Shunt System under the latest EU Medical Device...

Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards
The Health Alliance Continues to Disrupt Healthcare with Rapid Expansion into Indiana and West Virginia

The Health Alliance, a leading national value-based care company continues to reshape healthcare delivery with its rapid expansion. The organization has recently opened new medical centers in Indiana and West Virginia,...

The Health Alliance Continues to Disrupt Healthcare with Rapid Expansion into Indiana and West Virginia
Clairyon Launches to Improve Quality and Patient Care

Healcisio, Inc. has rebranded as Clairyon, signaling the company's transition into a phase of rapid growth and commercialization. This milestone is highlighted by the appointment of Brenda Schmidt as CEO and Dr....

Clairyon Launches to Improve Quality and Patient Care
Association of periOperative Registered Nurses (AORN) Names David Wyatt as New CEO and Executive Director

The Association of periOperative Registered Nurses (AORN) is pleased to announce the appointment of David Wyatt, PhD, RN, NEA-BC, CNOR, FAORN, FAAN, as its new Chief Executive Officer and Executive Director, effective...

Association of periOperative Registered Nurses (AORN) Names David Wyatt as New CEO and Executive Director
Endevica Bio to Start Phase 2 Clinical Trial of Drug to Prevent Weight Loss in Cancer Patients

Endevica Bio, a privately held company developing first-in-class peptide drug candidates, today announced the start of a Phase 2 clinical trial of its experimental drug TCMCB07 (B07) to prevent weight loss in certain...

Endevica Bio to Start Phase 2 Clinical Trial of Drug to Prevent Weight Loss in Cancer Patients
Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and...

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration
Antaisolar Releases Its First ESG Report, Highlighting Commitment to Sustainable Development

Antaisolar, expert in digital intelligent PV mounting system solutions, has officially published its first Environmental, Social, and Governance (ESG) report, marking a significant step in its commitment to sustainable...

Antaisolar Releases Its First ESG Report, Highlighting Commitment to Sustainable Development
TRYNGOLZA™ (olezarsen) approved in U.S. as first-ever treatment for adults living with familial chylomicronemia syndrome as an adjunct to diet

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration (FDA) has approved TRYNGOLZA™ (olezarsen) as an adjunct to diet to reduce triglycerides in adults with familial...

TRYNGOLZA™ (olezarsen) approved in U.S. as first-ever treatment for adults living with familial chylomicronemia syndrome as an adjunct to diet
FDA Grants IDE Approval for the Pivotal Trial of the JuxtaFlow® Renal Assist Device (RAD)

Roivios, a pioneering clinical-stage medical device company dedicated to revolutionizing kidney health, proudly announces that its research and development arm, 3ive Labs, has secured approval for an Investigational Device...

FDA Grants IDE Approval for the Pivotal Trial of the JuxtaFlow® Renal Assist Device (RAD)
StemCyte Announces Successful Phase IIa Clinical Trial Results for HPC, Cord Blood in Treating Post-COVID Syndrome: 85% of Patients Experience Complete Relief from Fatigue Symptoms

StemCyte announced a significant breakthrough in its Phase IIa clinical trial of HPC, Cord Blood (HPC, CB) for treating Post-COVID Syndrome (Long COVID). This trial results demonstrated that cord blood significantly...

StemCyte Announces Successful Phase IIa Clinical Trial Results for HPC, Cord Blood in Treating Post-COVID Syndrome: 85% of Patients Experience Complete Relief from Fatigue Symptoms
OrthAlign, Inc. Announces First Cases Using Lantern® Hip; The Next Evolution in Total Hip Replacement Technology.

OrthAlign, Inc. today announced a significant milestone with the successful first clinical use of its Lantern Hip handheld technology. The procedure was performed by Edwin Su, MD, a renowned orthopedic surgeon at the...

OrthAlign, Inc. Announces First Cases Using Lantern® Hip; The Next Evolution in Total Hip Replacement Technology.
TIM TEBOW HONORED AT VICTORIA'S VOICE FOUNDATION'S GALA WITH DAVID SIEGEL HERO AWARD

Tim Tebow was honored at Victoria's Voice Foundation's annual gala on December 15, receiving the David Siegel Hero Award for his work fighting for the world's most vulnerable people. Tebow, a two-time national...

TIM TEBOW HONORED AT VICTORIA'S VOICE FOUNDATION'S GALA WITH DAVID SIEGEL HERO AWARD
PrairieCare Celebrates 100,000th Patient Milestone Along with Expansion of Capacity and Services

PrairieCare, a leader in specialized, evidence-based psychiatric services for people of all ages, is celebrating its 100,000th patient since opening its hospital in 2011, and a successful 2024 in which nearly 20,000...

PrairieCare Celebrates 100,000th Patient Milestone Along with Expansion of Capacity and Services
doTERRA Partners with Save the Children and Cobie Smulders to Support Underserved Communities Across the U.S.

doTERRA, the world leader of essential oils and wellness products, has partnered with global humanitarian organization Save the Children to provide thousands of wellness kits to support children and families across the...

doTERRA Partners with Save the Children and Cobie Smulders to Support Underserved Communities Across the U.S.
PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation Announce $11M Investment to Advance PMB-CT01 (BAFF-R CAR T cell therapy) for Relapsed/Refractory Follicular Lymphoma

PeproMene Bio, Inc. (PMB) has announced an $11M investment from the Institute for Follicular Lymphoma Innovation (IFLI) to support the clinical development of PMB-CT01 (BAFF-R CAR T cell therapy) in patients with relapsed...

PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation Announce $11M Investment to Advance PMB-CT01 (BAFF-R CAR T cell therapy) for Relapsed/Refractory Follicular Lymphoma
Andromeda Surgical Announces World's First Robotic-Assisted HoLEP Procedure

Surgical robotics pioneer Andromeda Surgical today announced a groundbreaking milestone: Dr. Cristián Trucco of Universidad Católica performed the world's first robotic-assisted holmium laser enucleation of the...

Andromeda Surgical Announces World's First Robotic-Assisted HoLEP Procedure
Aetna Adds Spanish Language Capabilities for Health App to Better Serve Diverse Populations

Aetna, a CVS Health company, has expanded the functionality of the Aetna Health? app to include Spanish language capabilities for all eligible health plan members, regardless of how or where they are covered.

Aetna Adds Spanish Language Capabilities for Health App to Better Serve Diverse Populations
Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that it has entered into a...

Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters
Beko earns the highest ESG score in the DHP Household Durables Industry in the S&P Global Corporate Sustainability Assessment

Beko**, a global leader in consumer durables and electronics, has achieved an outstanding score of 89/100 (Score date: 22/11/24) in the 2024 S&P Global Corporate Sustainability Assessment (CSA) highlighting its...

Beko earns the highest ESG score in the DHP Household Durables Industry in the S&P Global Corporate Sustainability Assessment
Dark Genome Biotech HERVolution Therapeutics Announces $11.7M Series A to Advance Treatments for Cancer & Diseases of Aging

HERVolution Therapeutics ApS ('HERVolution'), a dark genome-focused biotechnology company developing immunotherapies to address aging-related diseases, today announced a $11.7 million Series A financing to advance...

Dark Genome Biotech HERVolution Therapeutics Announces $11.7M Series A to Advance Treatments for Cancer & Diseases of Aging
LG Corp. Chairman and CEO Kwang Mo Koo sends 2025 New Year Address to 270,000 global employees on December 19

LG Corp. Chairman and CEO Kwang Mo Koo delivered his annual New Year's greetings via video email to approximately 270,000 LG employees worldwide. This continues a tradition begun in 2022 of delivering the New...

LG Corp. Chairman and CEO Kwang Mo Koo sends 2025 New Year Address to 270,000 global employees on December 19
Fangzhou Inc. and Bristol Myers Squibb China Join Forces on a Strategic Alliance to Advance Internet Healthcare

Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a pioneer in Internet healthcare solutions, announced a strategic alliance with Bristol Myers Squibb ("BMS") China on December 16th. The partnership was officially...

Fangzhou Inc. and Bristol Myers Squibb China Join Forces on a Strategic Alliance to Advance Internet Healthcare
Medicus Healthcare Solutions Releases Report on the Future of Hospital Medicine

Leading interim healthcare staffing agency Medicus Healthcare Solutions has released a report titled Preparing for the Future of Hospital Medicine: Addressing Workforce Challenges and Increasing Demand. This data-driven...

Medicus Healthcare Solutions Releases Report on the Future of Hospital Medicine
Endeavor Health awarded $2m Department of Justice grant for community violence prevention and intervention program

Endeavor Health? has been awarded a $2 million, three-year grant from the U.S. Department of Justice Office of Justice Programs to address community violence through mental health resources, directly supporting individuals...

Endeavor Health awarded $2m Department of Justice grant for community violence prevention and intervention program
Gastro Concepts Receives FDA Clearance for Air Assist™ Device, Revolutionizing Colonoscopy Procedures

Gastro Concepts, a team committed to advancing safety and efficiency in gastroenterology, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its groundbreaking Air Assist™ device....

Gastro Concepts Receives FDA Clearance for Air Assist™ Device, Revolutionizing Colonoscopy Procedures
Futures Recovery Healthcare Announces New Leadership Team: Dr. Tammy Malloy Named CEO and Kate Armstrong Appointed COO

Futures Recovery Healthcare is pleased to announce the appointment of Dr. Tammy Malloy?as Chief Executive Officer (CEO) and Kate Armstrong?as Chief Operating Officer (COO). These leadership changes mark a pivotal moment...

Futures Recovery Healthcare Announces New Leadership Team: Dr. Tammy Malloy Named CEO and Kate Armstrong Appointed COO
/C O R R E C T I O N -- Connections Health Solutions/

Connections Health Solutions, the leading innovator in immediate-access emergency behavioral health care, commends Congressmen Tony Cárdenas (CA-29), David Schweikert (AZ-1), Brian Fitzpatrick (PA-1), and Marc Veasey...

/C O R R E C T I O N -- Connections Health Solutions/
SafeRide Health Opens New San Antonio Headquarters, Helping Vulnerable Patients Nationwide Access Life-Sustaining Care

SafeRide Health, one of the nation's leading non-emergency medical transportation companies, officially opened its new headquarters in San Antonio this week. The space was designed to deliver industry-leading...

SafeRide Health Opens New San Antonio Headquarters, Helping Vulnerable Patients Nationwide Access Life-Sustaining Care
Breckenridge announces final FDA approval for Methadone Hydrochloride Multi-Dose Injection

Breckenridge Pharmaceutical, Inc., the U.S. subsidiary of Towa International that markets, distributes, and sells generic pharmaceuticals in the United States, announced today that the U.S. Food and Drug Administration has...

Breckenridge announces final FDA approval for Methadone Hydrochloride Multi-Dose Injection
Mercy Names New Chief Operating Officer: First Physician to Lead All Operations

Mercy names Dr. John Mohart as its executive vice president and chief operating officer (COO) ? the first time a physician has been named to the COO role across Mercy.

Mercy Names New Chief Operating Officer: First Physician to Lead All Operations
Connections Health Solutions Applauds Bipartisan Legislation to Expand Behavioral Health Crisis Services for Medicare Beneficiaries

Connections Health Solutions, the leading innovator in immediate-access emergency behavioral health care, commends Congressmen Tony Cárdenas (CA-29), David Schweikert (AZ-1) and Brian Fitzpatrick (PA-1) for introducing the...

Connections Health Solutions Applauds Bipartisan Legislation to Expand Behavioral Health Crisis Services for Medicare Beneficiaries
CND Life Sciences Announces Publication of Study Demonstrating Clinical Utility of the Syn-One Test® as an Important Aid in the Diagnosis and Treatment of Neurodegenerative Diseases

CND Life Sciences (CND), a medical technology company pioneering the development of cutaneous neurodiagnostic tests and associated biomarker services, today announced the publication of a study in the Movement Disorders...

CND Life Sciences Announces Publication of Study Demonstrating Clinical Utility of the Syn-One Test® as an Important Aid in the Diagnosis and Treatment of Neurodegenerative Diseases
Central Management Company awards Medline primary supplier agreement for medical-surgical products

Medline today announced a new prime vendor agreement with Louisiana-based Central Management Company. With more than 55 years of experience in the long-term care space, Central Management Company oversees skilled nursing...

Central Management Company awards Medline primary supplier agreement for medical-surgical products
HospiceChoice Rx Team Grows with the Addition of Shelly Mikuls as Director of Business Development

HospiceChoice Rx is pleased to announce its most recent hire, Shelly Mikuls. Ms. Mikuls will join the company starting in January as Director of Business Development. She brings more than 17 years of Hospice experience, 6...

HospiceChoice Rx Team Grows with the Addition of Shelly Mikuls as Director of Business Development
Orthopedic Care Partners Announces New President and Chief Operating Officer

Orthopedic Care Partners ("OCP" or the "Organization"), a leading orthopedic practice management platform, today announced the appointment of Ed Tufaro as President and Chief Operating Officer (COO).

Orthopedic Care Partners Announces New President and Chief Operating Officer
GENEXA, THE PIONEER OF CLEAN MEDICINE, NAMES MICHAEL LYNCH AS PRESIDENT

Genexa, the first clean medicine brand, is proud to announce the appointment of Michael Lynch as President. A proven leader with deep expertise in scaling purpose-driven brands, Lynch will guide Genexa as it continues to...

GENEXA, THE PIONEER OF CLEAN MEDICINE, NAMES MICHAEL LYNCH AS PRESIDENT
Withings BPM Pro 2 is now FDA Cleared and Named CES 2025 Innovation Awards Honoree for Digital Health

Withings Health Solutions, the professional healthcare division of Withings, today announced that its BPM Pro 2, a first-of-its-kind cellular blood pressure monitor that integrates and automates many aspects of clinical...

Withings BPM Pro 2 is now FDA Cleared and Named CES 2025 Innovation Awards Honoree for Digital Health
Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, in Combination with Semaglutide, Demonstrated Superior Weight Loss to Semaglutide Monotherapy in a Preclinical Model

Ascletis Pharma Inc. (HKEX:1672, "Ascletis") announces encouraging efficacy results from its study in diet-induced obese (DIO) mice combining ASC47, a first-in-class muscle-preserving weight loss drug candidate for the...

Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, in Combination with Semaglutide, Demonstrated Superior Weight Loss to Semaglutide Monotherapy in a Preclinical Model
SpinaFX Completes its Series B Funding Round

Advancing Innovative Spinal Treatment for Contained Herniated Discs

SpinaFX Completes its Series B Funding Round
Encompass Health Announces Preliminary Plans to Build a 50-bed Inpatient Rehabilitation Hospital in Bangor

Encompass Health Corp. (NYSE: EHC) today announced preliminary plans to build a freestanding, 50-bed inpatient rehabilitation hospital to be located at 1017 Union Street in Bangor, Maine.

Encompass Health Announces Preliminary Plans to Build a 50-bed Inpatient Rehabilitation Hospital in Bangor
Atreon Orthopedics Surpasses 10,000 Surgeries with ROTIUM® Bioresorbable Wick for Rotator Cuff Repairs, Foreshadowing Rapid Expansion of Regenerative Platform

Atreon Orthopedics, a Columbus-based innovator in tissue healing and regenerative technologies, is proud to announce a significant milestone: the successful use of its ROTIUM® Bioresorbable Wick in over 10,000 rotator cuff...

Atreon Orthopedics Surpasses 10,000 Surgeries with ROTIUM® Bioresorbable Wick for Rotator Cuff Repairs, Foreshadowing Rapid Expansion of Regenerative Platform
Spyre Therapeutics Added to the Nasdaq Biotechnology Index

Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches to target improved efficacy...

Spyre Therapeutics Added to the Nasdaq Biotechnology Index
HARMONY BIOSCIENCES TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Jeffrey M. Dayno, M.D., President and Chief Executive Officer,...

HARMONY BIOSCIENCES TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
Viatris Announces Publication of Phase 2b CARE Study Data for Cenerimod in Lancet Rheumatology

Viatris Inc. (NASDAQ: VTRS) today announced the publication of Phase 2b CARE study results evaluating the efficacy and safety of cenerimod in adults with moderate-to-severe systemic lupus erythematosus (SLE). The results,...

Viatris Announces Publication of Phase 2b CARE Study Data for Cenerimod in Lancet Rheumatology
Gan & Lee Pharmaceuticals Announces U.S. FDA Clearance of the IND application for the innovative Bi-weekly GLP-1RA GZR18 Injection, Bofanglutide, with chronic weight management Indication (A Phase 2 head-to-head with Tirzepatide clinical trial)

Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087.SH), is pleased to announce that the Food and Drug Administration (" FDA ") has cleared the Investigational New Drug (IND) application for GZR18...

Gan & Lee Pharmaceuticals Announces U.S. FDA Clearance of the IND application for the innovative Bi-weekly GLP-1RA GZR18 Injection, Bofanglutide, with chronic weight management Indication (A Phase 2 head-to-head with Tirzepatide clinical trial)
Foothill Regional Medical Center Infection Control Expert Receives Top National Honor

Shahbaz Salehi, MPH, MSHIA, director, infection control, at Foothill Regional Medical Center, has been named the 2024 Educator of the Year by Infection Control Today, a national leader in infection control.

Foothill Regional Medical Center Infection Control Expert Receives Top National Honor
U.S. FDA approves Celltrion's STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab)

Celltrion announced today that the U.S. Food and Drug Administration (FDA) has approved STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), for subcutaneous injection or intravenous infusion in adult and...

U.S. FDA approves Celltrion's STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab)
Lilly's Kisunla™ (donanemab-azbt) Approved in China for the Treatment of Early Symptomatic Alzheimer's Disease

Eli Lilly and Company (NYSE: LLY) today announced that the National Medical Products Administration (NMPA) in China has approved Kisunla™ (donanemab-azbt, 350 mg/20 mL every four weeks injection for IV infusion), Eli Lilly...

Lilly's Kisunla™ (donanemab-azbt) Approved in China for the Treatment of Early Symptomatic Alzheimer's Disease
Nemours Children's Hospital, Florida Announces $300 Million Expansion

As part of its overall commitment to pediatric health, Nemours Children's Health will invest $300 million in Central Florida over the next four years to meet growing needs for highest-quality pediatric care.

Nemours Children's Hospital, Florida Announces $300 Million Expansion
FDA Roundup: December 17, 2024

Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:

FDA Roundup: December 17, 2024
Ascend produces bio-circular performance chemicals, PA66

Ascend Performance Materials announced today the successful production of acrylonitrile, hexamethylene diamine, adipic acid and nylon 6,6 from feedstocks derived from used cooking oil, expanding its Bioserve portfolio. The...

Ascend produces bio-circular performance chemicals, PA66
Kidney Patients Interested and Anxious on Xenotransplantation Clinical Trials

Pig kidneys may be the key to addressing the nation's severe organ shortage crisis, and patients are eager for clinical trials to begin. That's a key finding in the National Kidney Foundation's (NKF) newly...

Kidney Patients Interested and Anxious on Xenotransplantation Clinical Trials
Phoenix Children's Ranks Among Top 100 Healthiest Workplaces in the U.S. in 2024

Phoenix Children's, one of the nation's fastest-growing pediatric healthcare systems, was named among the "Healthiest 100 Workplaces in America" by Healthiest Employers®, a program honoring people-first...

Phoenix Children's Ranks Among Top 100 Healthiest Workplaces in the U.S. in 2024
Neuvotion Expands Partnership with Intelligent Product Solutions and Commercializes NeuStim™ Technology for Stroke and Spinal Cord Injury

Neuvotion, Inc. is an early-stage medical device company developing AI-driven neuromodulation technologies and products for use in the neurorehabilitation, brain-computer interface (BCI), and physical therapy markets....

Neuvotion Expands Partnership with Intelligent Product Solutions and Commercializes NeuStim™ Technology for Stroke and Spinal Cord Injury
TruDiagnostic Introduces Revolutionary Epigenetic Biomarker Proxies: New Diagnostic Approach Outperforms Traditional Lab Results

LEXINGTON, Ky., Dec. 17, 2024 /PRNewswire/ -- TruDiagnostic, a global leader in advanced epigenetic research, proudly announces a groundbreaking advancement in precision medicine: the development of Epigenetic Biomarker...

TruDiagnostic Introduces Revolutionary Epigenetic Biomarker Proxies: New Diagnostic Approach Outperforms Traditional Lab Results
Zynex Announces Partnership To Conduct Business with Veterans Affairs (VA) Medical Centers, the Largest Healthcare Network in the United States

Zynex, Inc. (NASDAQ: ZYXI) ("Zynex", "ZMS", "we" or the "Company"), an innovative medical technology company specializing in the manufacture and sale of noninvasive medical devices for pain management, rehabilitation, and...

Zynex Announces Partnership To Conduct Business with Veterans Affairs (VA) Medical Centers, the Largest Healthcare Network in the United States
Moon Surgical Appoints Chris Toth as Independent Board Member Ahead of Commercial Acceleration

Moon Surgical, a pioneer in laparoscopic surgical innovation, today announced the appointment of Chris Toth as an independent member of its Board of Directors. With over 20 years of experience in scaling and managing...

Moon Surgical Appoints Chris Toth as Independent Board Member Ahead of Commercial Acceleration
Points East Veterinary Specialty Hospital Achieves Veterinary Emergency and Critical Care Society (VECCS) Facility Certification

Points East Veterinary Specialty Hospital is proud to announce its recent certification as a Level III Facility by the Veterinary Emergency and Critical Care Society (VECCS). This recognition underscores the hospital's...

Points East Veterinary Specialty Hospital Achieves Veterinary Emergency and Critical Care Society (VECCS) Facility Certification
Rula Health Appoints Two Senior Leaders, Positioning the Company for Continued Growth in 2025

Rula Health, a behavioral health company focused on improving access to high-quality, personalized, and in-network mental healthcare, today announced the appointments of Mark Khavkin as Chief Financial Officer and...

Rula Health Appoints Two Senior Leaders, Positioning the Company for Continued Growth in 2025
NEW PAPER: Health Plan Barriers Block Care for Patients with Hypertrophic Cardiomyopathy

Accessing treatment can be difficult for the up to one in 250 people who live with hypertrophic cardiomyopathy, a condition that causes the heart muscle to thicken, making it harder for the heart to pump blood. "Optimizing...

NEW PAPER: Health Plan Barriers Block Care for Patients with Hypertrophic Cardiomyopathy
Mitsubishi Tanabe Pharma America Announces Research Collaboration Between Mitsubishi Tanabe Pharma Corporation and Dewpoint Therapeutics to Advance Small Molecule Condensate Modulator for ALS

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that Mitsubishi Tanabe Pharma Corporation (MTPC), its parent company and a global leader in neurological disease therapeutics, has entered into a strategic...

Mitsubishi Tanabe Pharma America Announces Research Collaboration Between Mitsubishi Tanabe Pharma Corporation and Dewpoint Therapeutics to Advance Small Molecule Condensate Modulator for ALS
Avertix Medical Bolsters Board of Directors with Key Additions

Avertix Medical, a cutting-edge medical device company offering the first and only FDA-approved Class III implantable device that can detect silent and atypical symptomatic heart attacks in real-time, announced significant...

Avertix Medical Bolsters Board of Directors with Key Additions
Sairopa reports research milestones achieved in partnership with Exelixis, totalling $35 Million from consecutive clinical milestone payments in 2024

Sairopa B.V., today announced it has achieved a milestone event in its exclusive clinical development and option agreement with Exelixis, Inc. (Nasdaq: EXEL) involving ADU-1805, an innovative anti-SIRPa antibody with the...

Sairopa reports research milestones achieved in partnership with Exelixis, totalling $35 Million from consecutive clinical milestone payments in 2024
Abbott Announces First-in-World Leadless Pacing Procedures in the Left Bundle Branch Area of the Heart

Abbott (NYSE: ABT) today announced the successful completion of the world's first in-human leadless left bundle branch area pacing (LBBAP) procedures using the company's investigational AVEIR™ Conduction System...

Abbott Announces First-in-World Leadless Pacing Procedures in the Left Bundle Branch Area of the Heart
Lilly and EVA Pharma announce regulatory approval and release of locally manufactured insulin in Egypt

The Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA Pharma through a collaboration with Eli Lilly and Company (NYSE: LLY). Launched in 2022, the collaboration aims to deliver a...

Lilly and EVA Pharma announce regulatory approval and release of locally manufactured insulin in Egypt
Great Bay Bio Completes First Close of Series B Financing

Great Bay Bio (GBB) is thrilled to announce the successful first close of its Series B financing round. This milestone was achieved with the round led by a syndication of a well-known strategic investment institution and...

Great Bay Bio Completes First Close of Series B Financing
Ultima Markets makes history as the first CFD broker to join the United Nations Global Compact initiative

Ultima Markets, a leading CFD trading services provider, is proud to announce that it has joined the United Nations Global Compact initiative, becoming the first CFD broker to participate in this drive.

Ultima Markets makes history as the first CFD broker to join the United Nations Global Compact initiative
Zephyrus Innovations Announces First in World Injectable Closed System Transfer Device

Zephyrus Innovations (Zephyrus), a privately-owned medical device company designing and manufacturing safety syringes and Closed System Transfer Devices (CSTDs), announced its latest product, VaporShield, the world's...

Zephyrus Innovations Announces First in World Injectable Closed System Transfer Device